Loading organizations...
Loading organizations...
Pharmaceutical company focused on drug development.
Cour Pharmaceuticals Development has raised $135.0M across 2 funding rounds.
Cour Pharmaceuticals Development has raised $135.0M in total across 2 funding rounds.
Cour Pharmaceuticals Development has raised $135.0M in total across 2 funding rounds.
Cour Pharmaceuticals Development's investors include Alpha Wave Ventures, Benjamin Rovinski, Ph.D., Angelini Ventures, Bristol Myers Squibb, JDRF, Pfizer, Simon Greenwood, Chris Dimitropoulos.
Cour Pharmaceuticals Development has raised $135.0M across 2 funding rounds. Most recently, it raised $105.0M Series A in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 30, 2024 | $105.0M Series A | Alpha Wave Ventures, Benjamin Rovinski, Ph.D. | Angelini Ventures, Bristol Myers Squibb, JDRF, Pfizer, Simon Greenwood |
| Sep 7, 2022 | $30.0M Other Equity | Chris Dimitropoulos |